PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 40 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 5,556,778 | $4,695,000 | 0.39% |
| GREAT POINT PARTNERS LLC | 3,500,000 | $2,958,000 | 0.27% |
| HARBOURVEST PARTNERS LLC | 440,627 | $372,000 | 0.16% |
| VHCP Management III, LLC | 221,267 | $187,000 | 0.12% |
| VHCP Management II, LLC | 130,733 | $110,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 184,955 | $156,000 | 0.02% |
| Bain Capital Public Equity Management II, LLC | 202,050 | $171,000 | 0.02% |
| Kazazian Asset Management, LLC | 12,769 | $11,000 | 0.02% |
| Rock Springs Capital Management LP | 400,000 | $338,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 138,056 | $117,000 | 0.01% |